Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Retinas at Risk: Real-World Cases in High Disease Activity and Adherence Challenges
Carl D. Regillo, MD, FACS, FASRS
Lejla Vajzovic, MD, FASRS
Beyond Anti-VEGF: The Emerging Durability Landscape
Szilard Kiss, MD
Gene Therapy for nAMD: Navigating the Next Era of Durable Retinal Treatment
Seeing the Cornea Clearly
Jacob Lang
Rethinking Dry Eye Disease: Evolving Strategies for Evaluation and Care
Steve Jackson, PharmD
Esen K. Akpek, MD
Seeing the Signs of Dry Eye Disease
John D. Sheppard, MD
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
EMPOWER - Ocular Surface Disease: Latest Innovations In Dry Eye And Meibomian Gland Dysfunction
Josh Davidson, OD, FSLS, FAAO
Mark Dunbar
Interpreting Gene Therapy Data With Confidence
Adverse Event Mitigation in Gene Therapy for nAMD
How Gene Therapy Is Designed to Work in Retinal Disease
Gene Therapy for nAMD: Focus on Future Readiness
Uncovering the Drivers of Dry Eye Symptoms
Anat Galor, MD, MSPH
Patient-Centered Care in Dry Eye Disease
Kaleb Abbott, OD, FAAO
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Diagnostic Vitrectomy for Infectious Uveitis
Steven Yeh, MD, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.